- Home
- KZIA vs MRM Comparison
KZIA vs MRM Comparison
Compare KZIA & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- MRM
- Stock Information
- Founded
- KZIA 1994
- MRM 2000
- Country
- KZIA Australia
- MRM Japan
- Employees
- KZIA N/A
- MRM N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- MRM Other Consumer Services
- Sector
- KZIA Health Care
- MRM Consumer Discretionary
- Exchange
- KZIA Nasdaq
- MRM Nasdaq
- Market Cap
- KZIA 12.6M
- MRM 12.2M
- IPO Year
- KZIA 1999
- MRM 2020
- Fundamental
- Price
- KZIA $4.90
- MRM $2.64
- Analyst Decision
- KZIA Strong Buy
- MRM
- Analyst Count
- KZIA 1
- MRM 0
- Target Price
- KZIA $20.00
- MRM N/A
- AVG Volume (30 Days)
- KZIA 148.4K
- MRM 11.0K
- Earning Date
- KZIA 11-19-2024
- MRM 12-30-2022
- Dividend Yield
- KZIA N/A
- MRM N/A
- EPS Growth
- KZIA N/A
- MRM N/A
- EPS
- KZIA N/A
- MRM 0.16
- Revenue
- KZIA $382.00
- MRM $48,438,179.00
- Revenue This Year
- KZIA $4,053,954.00
- MRM N/A
- Revenue Next Year
- KZIA N/A
- MRM N/A
- P/E Ratio
- KZIA N/A
- MRM $16.64
- Revenue Growth
- KZIA N/A
- MRM N/A
- 52 Week Low
- KZIA $1.90
- MRM $2.27
- 52 Week High
- KZIA $15.80
- MRM $8.39
- Technical
- Relative Strength Index (RSI)
- KZIA 50.25
- MRM 44.19
- Support Level
- KZIA $5.21
- MRM $2.51
- Resistance Level
- KZIA $6.88
- MRM $2.81
- Average True Range (ATR)
- KZIA 0.76
- MRM 0.26
- MACD
- KZIA -0.11
- MRM 0.00
- Stochastic Oscillator
- KZIA 22.80
- MRM 40.00
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.